This is a prospective double-blind, randomized, parallel-group, placebo-controlled trial designed to examine the effect of supplementation with 50,000 IU vitamin D3 for 3 months on Polycystic Ovary Syndrome (PCOS) prognosis, serum 25-Hydroxy Vitamin D (25(OH)D) level, serum chromium level, insulin resistance, and Body Mass Index (BMI), in 60 overweight Jordanian female patients diagnosed with PCOS and with hypovitaminosis D.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Ultrasound Examination of Number of Follicles and Ovarian Volume
Timeframe: 3 months
Menstrual Regularity
Timeframe: 3 months
Hirsutism Score
Timeframe: 3 months
Serum Progesterone Level
Timeframe: 3 months
Total Testosterone Level
Timeframe: 3 months
Free Androgen Index
Timeframe: 3 months
Sex Hormone Binding Globulin Concentration
Timeframe: 3 months